Study Site — Denver, Colorado

Study Site is a clinical research site located in Denver, Colorado, United States 80230.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 4 clinical trials.

Therapeutic areas: Food Allergy, Alpha1-proteinase Inhibitor Deficiency, Emphysema.

Sponsors: Alladapt Immunotherapeutics, Inc., CSL Behring, Innovation Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 4 clinical trials on record. Their work covers Food Allergy, Alpha1-proteinase Inhibitor Deficiency, Emphysema.

Is Study Site accredited by Crixeo Health?

Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.